529P Exploratory study for preventing nausea and vomiting by switching from pranisetron + dexamethasone (Days 1–3) + aprepitant (Days 1–3) to palonosetron + pexamethasone (Day 1) in patients undergoing moderately emetogenic chemotherapy
2015 ◽
Vol 21
(3)
◽
pp. 491-497
◽
2014 ◽
Vol 27
(5)
◽
pp. 412-418
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 9633-9633
◽
2013 ◽
Vol 22
(4)
◽
pp. 905-909
◽
2014 ◽
Vol 47
(3)
◽
pp. 542-550
◽
2013 ◽
Vol 55
(3)
◽
pp. 544-550
◽